-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Haemonetics, Raises Price Target to $130

Benzinga·10/08/2026 18:18:09
Listen to the news
BTIG analyst Marie Thibault maintains Haemonetics (NYSE:HAE) with a Buy and raises the price target from $110 to $130.